BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28802496)

  • 1. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
    Lang UE; Yeh I; McCalmont TH
    Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
    Kiavash K; Bluth MH; Thompson AD
    Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
    High WA
    Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
    Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
    Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
    March J; Hand M; Truong A; Grossman D
    J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing for melanocytic tumors: a practical update.
    Andea AA
    Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
    Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
    Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral heterogeneity of chromosome 9 loss and CDKN2A (p16) protein expression in a morphologically challenging spitzoid melanoma.
    DiSano K; Tschen JA; Cho-Vega JH
    Am J Dermatopathol; 2013 Apr; 35(2):277-80. PubMed ID: 23221484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
    Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
    Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number variations and clinical outcome in atypical spitz tumors.
    Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
    Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
    Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
    Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.
    Tom WL; Hsu JW; Eichenfield LF; Friedlander SF
    J Am Acad Dermatol; 2011 Mar; 64(3):559-72. PubMed ID: 21255872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma.
    Zedek DC; McCalmont TH
    Clin Lab Med; 2011 Jun; 31(2):311-20. PubMed ID: 21549244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.